A leader in neuro-scientific regenerative medicine.

Collectively, degenerative eye illnesses afflict over 25 million people in the U.S. And Europe by itself. These diseases have a devastating effect on patients and their own families, which offers been a solid motivating element for developing this fresh treatment. In Stargardt’s disease, the loss of RPE cells in the patient’s macula causes a loss of photoreceptors – the cones and rods with which we see – leading to blindness. We believe that transplanting new, healthful RPE cells may provide a highly effective treatment for SMD and perhaps various other macular degenerative diseases such as for example dry AMD.Delgado, III, M.D., James W. Long, M.D., Ph.D., Thomas C. Wozniak, M.D., Waqas Ghumman, M.D., David J. Farrar, Ph.D., and O. Howard Frazier, M.D. For the HeartMate II Investigators: Advanced Heart Failing Treated with Continuous-Movement Still left Ventricular Assist Device.

Alberta Children’s Hospital performs first liver cell transplant in Calgary, Canada A three-month-old Winnipeg girl has become the first individual in Canada to get an experimental and potentially life-saving type of therapy to improve the function of her liver. Doctors at Alberta Children's Hospital, led by medical geneticist Dr. Aneal Khan, successfully completed a series of liver cell transplants previous this month on individual Nazdana Ali.